Parametric Portfolio Associates’s Sharps Compliance Corp SMED Stock Holding History

Parametric Portfolio Associates’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$59K	Buy	+10,026	New	+$63K	﹤0.01%	3619

Other funds holding SMED

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

Parametric Portfolio Associates's SMED Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Sharps Compliance Corp (SMED) in Q1 2022: 10,026 shares worth $59K. The stake represents ﹤0.01% of the portfolio and ranks #3619 among its holdings.

80 funds tracked by Wall St. Rank hold SMED as of Q1 2022.

Parametric Portfolio Associates held 10,026 shares of Sharps Compliance Corp worth $59K as of Q1 2022.
Sharps Compliance Corp was a new Parametric Portfolio Associates position in Q1 2022.
Sharps Compliance Corp made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3619 holding.
80 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.